Bixiye
QP39-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024
Natiijooyinka Raadinta
Soo bandhiga 1161 - 1170 ee natiijooyinka 3688
Bixiye
QP40-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024
Bixiye
2024 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2024
Bixiye
QP31-24 Rare Disease Benefit Mandate
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 10, 2024
Bixiye
2024 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2024
Bixiye
Risdiplam - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Metformin ER - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Sharciga & Xeerar
2024-annual-member-notice-website.pdf
Bixiye
QP43-24 MHCP Pharmacy Benefit Exclusion for Alyglo™ and Lenmeldy™
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024
Bixiye
QP42-24 Commercial Pharmacy Benefit Exclusion for Lenmeldy™
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024